Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001628280-21-004640
Filing Date
2021-03-12
Accepted
2021-03-12 16:10:47
Documents
13
Effectiveness Date
2021-03-12

Document Format Files

Seq Description Document Type Size
1 S-3ASR crdfs-3asr031221.htm S-3ASR 652866
2 EX-1.2 a12ex031221.htm EX-1.2 274698
3 EX-4.3 a43ex031221.htm EX-4.3 308833
4 EX-4.4 a44ex031221.htm EX-4.4 317776
5 EX-5.1 a51ex031221.htm EX-5.1 49196
6 EX-5.2 a52ex031221.htm EX-5.2 22749
7 EX-23.1 a231ex031221.htm EX-23.1 2864
8 cardiff_logoxrgbxtm3a.jpg GRAPHIC 176318
9 image_02.jpg GRAPHIC 34763
10 image_02b.jpg GRAPHIC 34763
11 image_21.jpg GRAPHIC 127
12 image_31.jpg GRAPHIC 302
13 image_71.jpg GRAPHIC 295
  Complete submission text file 0001628280-21-004640.txt   1955316
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-254217 | Film No.: 21737511
SIC: 2836 Biological Products, (No Diagnostic Substances)